Dulaglutide (TRULICITY) Phonetic pronunciation: DOO la GLOO tide / TRU li si tee Mnemonic: Truly a Doula glue tide US Sales rank: #149 Year of release: 2014 Price range: $735$1000 FDA-approved for: Type 2 diabetes Used off-label for: Weight loss Mechanism: GLP-1 receptor agonist Available doses: 0.75 mg , 1.5 mg, 3 mg , 4.5 mg Dynamic interactions: Glucose lowering Kinetic interactions: Delayed gastric emptying, otherwise none in a bubble Dulaglutide (Trulicity) is a GLP analog that reduces hemoglobin A1C by 1.5% to 1.8%, which is slightly more than other GLP analogs
They also have this claim on their website: This doesnt mean Happy Mammoth products themselves are scientifically backed or that theyve been featured in these outlets
Gastrointestinal adverse events were predominantly limited to initial dosing, while dose escalation resulted in lower discontinuation rates owing to these adverse events than among patients who remained on the starting dose
Sudden caloric restriction and medication exposure in early pregnancy warrant careful planning
Many plans require prior authorization, a BMI threshold, and documentation of previous failed weight loss attempts, and coverage is often denied for weight loss indications entirely
The FDA resolved the GLP-1 receptor agonists shortage in 2024, narrowing but not eliminating that pathway